Correction to: The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.